Guiding fibroblast activation using an RGD-mutated heparin binding II fragment of fibronectin for gingival titanium integration

The formation of a biological seal around the neck of titanium (Ti) implants is critical for ensuring integration at the gingival site and for preventing bacterialcolonization that may lead to periimplantitis. This process is guided byactivated fibroblasts, named myofibroblasts, which secrete extracellularmatrix (ECM) proteins and ECM-degrading enzymes resolving the wound.However, in some cases, Ti is not able to attract and activate fibroblasts to asufficient extent, which may compromise the success of the implant.Fibronectin (FN) is an ECM component found in wounds that is able to guidesoft tissue healing through the adhesion of cells and attraction of growthfactors (GFs). However, clinical use of FN functionalized Ti implants isproblematic because FN is difficult to obtain, and is sensitive to degradation.Herein, functionalizing Ti with a modified recombinant heparin binding II(HBII) domain of FN, mutated to include an Arg-Gly-Asp (RGD) sequence forpromoting both fibroblast adhesion and GF attraction, is aimed at. TheHBII-RGD domain is able to stimulate fibroblast adhesion, spreading,proliferation, migration, and activation to a greater extent than the nativeHBII, reaching values closer to those of full-length FN suggesting that itmight induce the formation of a biological sealing.
Peer Reviewed
Postprint (published version)